Mithridion develops drugs for central nervous system disorders, with special focus on schizophrenia and Alzheimer&s;s disease.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Madison
State: Wisconsin
Zip:
Country: United States
Mithridion is a biopharmaceutical company that discovers and develops drugs for central nervous system disorders, with an initial focus on Alzheimer&s;s disease and schizophrenia.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2007 | Series A | 4 | $2.2M |
Rosetta Partners Venture Investors Wisconsin Alumni Research Foundation Wisconsin Investment Partners Rosetta Partners Venture Investors Wisconsin Alumni Research Foundation Wisconsin Investment Partners |
1/2009 | Series B | 4 | $2.9M |
Rocket Ventures State of Wisconsin Investment Board Venture Investors Wisconsin Investment Partners Rocket Ventures State of Wisconsin Investment Board Venture Investors Wisconsin Investment Partners |
1/2011 | Series C | 3 | $1.3M |
Rocket Ventures Venture Investors Wisconsin Investment Partners Rocket Ventures Venture Investors Wisconsin Investment Partners |
---|
Announced Date | Name | Price |
---|---|---|
6/2008 | Cognitive Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|